TissueCypher® Provides Clinically-Impactful Risk Stratification in Patients with Barrett's Esophagus
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #BarretsEsophagus--Castle will share new data on its TissueCypher® test during the Presidential Plena...
September 8, 2023
8:30 PM
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #BarretsEsophagus--Castle will share new data on its TissueCypher® test during the Presidential Plenary Session of the 19th ISDE World Congress for Esophageal Diseases.